Corient Private Wealth LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 134 filers reported holding IMMUNITYBIO INC in Q3 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
Corient Private Wealth LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$293,555
+77.7%
173,701
+192.3%
0.00%
Q2 2023$165,213
+52.6%
59,429
-0.1%
0.00%
Q1 2023$108,257
-9.6%
59,482
+151.7%
0.00%
Q4 2022$119,80423,6300.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders